Showing results (1081-1090 of 4,424) with videos related to
Sort By:
Pageof 443
Cancer Cell International|December 28, 2022
Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancerMohammed Moustapha Anwar, Chris Albanese, Nadia M Hamdy, et al.Cancer Cell International|December 29, 2022
Interactions of melatonin with various signaling pathways: implications for cancer therapyAinaz Mihanfar, Bahman Yousefi, Bita Azizzadeh, et al.Cancer Cell International|June 13, 2022
Recent knowledge of NFATc4 in oncogenesis and cancer prognosisQiu-Hua Zhong, Si-Wei Zha, Andy T Y Lau, et al.Cancer Cell International|June 1, 2022
YOD1 serves as a potential prognostic biomarker for pancreatic cancerZhishuo Zhang, Wenxia Zhao, Yiming Li, et al.Cancer Cell International|December 2, 2022
HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53Tiebo Mao, Xiaofei Zhang, Haiyan Xu, et al.Cancer Cell International|December 2, 2022
Exosomal circular RNA: a signature for lung cancer progressionBashdar Mahmud Hussen, Snur Rasool Abdullah, Goran Sedeeq Hama Faraj, et al.Cancer Cell International|June 10, 2022
KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinomaYankang Cui, Tianyi Shen, Feng Xu, et al.Cancer Cell International|November 24, 2022
Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?Sara Shayan, Arash Arashkia, Kayhan AzadmaneshCancer Cell International|June 18, 2022
Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysisElham Kalantari, Mahdieh Razmi, Fatemeh Tajik, et al.Cancer Cell International|May 23, 2019
Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancersSmarajit Maiti, Aarifa NazmeenPageof 443